Aclaris Therapeutics (ACRS) - Cash per Share

Aclaris Therapeutics (ACRS) develops kinase inhibitors to combat immuno-inflammatory pathologies. The cash per share volume confirms the financial stability of the share price. Engaging external CDMO partners for substance production optimizes costs, while dependence on FDA approvals determines future growth. Consequently, 0.72 becomes the new value for the company's liquidity metric.
Analytical breakdowns for Aclaris Therapeutics, Inc. (ACRS)
- stock quotes and analyst forecast:
- market capitalization indicators:
- company book value details:
- company liabilities and liquidity data:
Total Debt to Capital Coefficient Aclaris Therapeutics|ACRS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Aclaris|ACRS - Company Total Debt|Debt to Book Capital Aclaris Therapeutics Inc.|ACRS - Company Long-Term Debts|Company Short-Term Loans and Borrowings Aclaris Therapeutics|Immediate Liquidity aclaristx.com
- earnings and valuation multiples indicators:
ACRS - Company Net Income|Expected Net Income Aclaris Therapeutics|ACRS - P/E Multiple|Forward P/E Multiple aclaristx.com|ACRS - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio Aclaris Therapeutics Inc.|ACRS - Operating profit EBITDA|Net earnings per one share for the last twelve months Aclaris Therapeutics|ACRS - Net earnings per share for the last 12 months|Quarterly EPS earnings growth aclaristx.com|ACRS - Net earnings per share growth this year|Projected earnings per share increase next year Aclaris Therapeutics
- company sales and revenue statistics:
- margin metrics data:
- cash availability and cash flow indicators:
General company analysis:Aclaris, ACRS

This metric is calculated by dividing the total volume of liquid assets by the number of outstanding shares, determining the actual cash reserve per share of ownership. For Aclaris Therapeutics (ACRS), the analysis of cash per share is critical, as sufficient capital ensures the funding of immune drug development and the subsequent scaling of their production.
Key competitors
ARGX - Cash Funds Volume per Share|Cash Funds per Share BioNTech (BNTX)|Cash Funds per Share ABVX (ABIVAX)|ADMA Biologics, Inc. - Cash per Single Share|Cash per Share Protagonist PTGX|IMVT - Cash Funds per Share|Cash Funds Calculated per Share Kiniksa Pharmaceuticals Ltd KNSA|grifols.com (GRFS) - Cash Funds per Share|ADPT (Adaptive Biotechnologies) - Cash Funds per Share|Cash per Single Share CLDX|AUPH: Amount of Cash per Share|Cash per Share BCRX|VERA (Vera Pharma) - Amount of Cash per Share|Dianthus Pharma - Cash per Single Share|Amount of Cash per Share PHVS|AbCellera Biologics - Cash per Share|Amount of Cash per Share TRML (Tourmaline Bio)|PGEN: Cash per Share|Cash on Hand per Share Pharming Group N.V. (PHAR)|Cash Funds per Share Nektar|upstreambio.com (UPB) - Cash Funds Calculated per Share|Cash Funds per Share Zenas Bio (ZBIO)|Cash Funds Calculated per Share Immunome Inc|Cash Funds per Share Gossamer Bio, Inc. GOSS|Cash per Share KalVista Pharmaceuticals Inc KALV|SEPN - Cash Funds per Share|PVLA - Cash per Share|SVRA: Cash per Share|RIGL - Cash Funds Calculated per Share|ANAB (AnaptysBio Inc) - Cash per Share|Cash per Single Share Astria Corp (ATXS)|Cash per Share ENGN|Cash Funds Calculated per Share rapt.com|Cash per Share JBIO (Aerovate Therapeutics Inc)|Cash Funds Calculated per Share Kyverna Therapeutics Inc. (KYTX)|TLSA - Cash Funds per Share|CABA: Cash Funds per Share|VTYX (Ventyx Biosciences, Inc.) - Cash per Single Share|THTX - Cash Funds Calculated per Share|AVTX (avalotx.com) - Cash per Share|Cash on Hand per Share Eledon Pharmaceuticals Inc. ELDN|Cash per Share AGEN|CLYM (Climb Bio, Inc.) - Amount of Cash per Share|Cash Funds per Share zurabio.com ZURA|ATYR - Cash per Single Share|Adagene Inc - Cash per Share|ImageneBio (IMA) - Cash per Single Share|Shattuck Therapeutics (STTK) - Cash Funds per Share|Cash on Hand per Share Equillium Inc (EQ)|Cash per Single Share CNTB|Cash Funds per Single Share IMUX (Immunic, Inc.)|Cash Funds per Share Atara Biotherapeutics, Inc. (ATRA)|IFRX - Cash on Hand per Share|Cash Funds Calculated per Share XFOR|Cash Funds Calculated per Share Adicet (ACET)|CELU - Cash Funds per Share|INMB (INmune Bio, Inc.) - Cash Funds per Single Share|BRNS: Cash per Share|Kezar Life Sciences Inc. (KZR) - Cash per Share|Cash Funds per Share SAB Biotherapeutics Inc|Cash per Share Akari Therapeutics, Plc|Cash Funds per Share Enlivex Therapeutics Ltd (ENLV)|QTTB - Cash on Hand per Share|Cash per Share GOVX (GeoVax Corp)|Edesa Biotech (EDSA) - Cash on Hand per Share|iBio Corporation - Cash per Share|CARM (carismatx.com) - Cash Funds per Single Share|XTLB (XTL Bio) - Cash per Single Share|Cash on Hand per Share Bolt Biotherapeutics Inc. (BOLT)|Cash per Single Share HCWB|Aptevo Therapeutics Inc. - Cash Money per Share|Cash Funds per Share AIM ImmunoTech, Inc. (AIM)|Cash per Share Aditxt Corp (ADTX)|Cash per Share GRI (GRI Bio Corporation)|XORTX Therapeutics (XRTX) - Cash on Hand per Share|HIND: Cash per Single Share|Cash on Hand per Share Revelation Bio|INDP: Cash per Share|Cash on Hand per Share BiondVax Pharmaceuticals (SCNI)|CALI (calcimedica.com) - Cash per Share|affimed.com (AFMD) - Cash Funds Calculated per Share|Cash Funds per Share Allakos (ALLK)|HOOK (HOOKIPA Pharma, Inc.) - Amount of Cash per Share|Cash Funds per Share igmbio.com IGMS|Amount of Cash per Share ITOS|oceanbiomedical.com - Cash per Share|TCBP - Cash per Share|Third Harmonic Bio, Inc (THRD) - Cash Funds per Share